SUNPHARMA's weekly return of 1.27% was modest, but its high volatility of 36.07% suggests that the stock was prone to significant price swings. Compared to its peers, SUNPHARMA underperformed, with a lower return and Sharpe Ratio than DRREDDY, DIVISLAB, and HINDUNILVR. The stock's Max Drawdown of -2.14% indicates that it was relatively risky this week.

[Volatility: 36.07%]